Meta Pixel

News and Announcements

Crowd Mobile Achieves Record Half Year Results with Revenue Up 53%

  • Published February 27, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Crowd Mobile Limited (ASX:CM8) has just reported record first half results for the six months to 31 December, 2016.

KEY TAKEAWAYS:

  • First Half Financial Highlight– Revenue up 53% to $21.5million.
  • First Half Divisional Highlights
    – Question & Answers (Q&A): Revenue up 16% to $10.6 million.
    – Paid Questions answered up 41% to $5.5 million.
    – Subscription: Revenue up 124% to % $10.9 million.
  • Second Half Operational Outlook
    – Outlook for H2-FY17 Results is an increase in all key financial metrics- Revenue, EBITDA, NPAT and Operating Cashflow compared to H1-FY17.
    – Foundations in place for ongoing expansion of integrated, global, mobile business positioned to deliver continued revenue growth.

Crowd Mobile has maintained a strong outlook for the second half of the 2017 financial year, on the back of revenue achieving 12-months high in January 2017 and Q&A achieving significant record.

The Company has strong foundations in place to continue their expansion in relation to integrated, global, mobile business to continued revenue growth.

Crowd Mobile’s Chief Executive Officer, Domenic Carosa: “Crowd Mobile’s strong first half performance has enabled us to springboard strongly into the second half and I expected increases in all key metrics.

The satisfying performance has been achieved thanks to record organic growth in our Q&A business and stabilisation within the Subscription division.

We also continue to investigate new growth opportunities and I am particularly excited about the digital influencer opportunities we are currently working on.

This year will be very exciting and I look forward to updating shareholders on progress with our new initiatives in addition to our ongoing strategic plan.”

Crowd Mobile CEO Domenic Carosa and CFO/COO Christian Shaw present the December half results via a 15 minute video presentation, please click here to view. 

Request Information 

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now